After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
MEMORANDUM OF UNDERSTANDING BETWEEN THE GOVERNMENT OF THE UNITED STATES OF AMERICA AND THE GOVERNMENT OF THE KINGDOM OF THAILAND CONCERNING COOPERATION TO DIVERSIFY GLOBAL CRITICAL MINERALS SUPPLY ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
Discover What’s Streaming On: I Don’t Understand You (now streaming on Hulu) attempts to weld culture-clash comedy to a gaycation to an adoption drama to a bloody horror-thriller, in pursuit of ...
What would you like to Propose? I propose adding flowcharts for selected algorithms to make it easier for beginners to understand the logic visually. Flowcharts will complement the existing code ...
Charli Carpenter directs Human Security Lab which has received funding from University of Massachusetts College of Social and Behavioral Sciences, the National Science Foundation, and the Lex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results